Differential risk of remission and ESRD in childhood FSGS.
about
Use of Cyclosporine Therapy in Steroid Resistant Nephrotic Syndrome (SRNS): A ReviewTargeted exome sequencing integrated with clinicopathological information reveals novel and rare mutations in atypical, suspected and unknown cases of Alport syndrome or proteinuriaThe Italian Society for Pediatric Nephrology (SINePe) consensus document on the management of nephrotic syndrome in children: Part I - Diagnosis and treatment of the first episode and the first relapseDiscovery and initial validation of α 1-B glycoprotein fragmentation as a differential urinary biomarker in pediatric steroid-resistant nephrotic syndrome.Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases.NGAL distinguishes steroid sensitivity in idiopathic nephrotic syndromeTherapeutic approach to FSGS in children.Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group.Clinical trial of focal segmental glomerulosclerosis in children and young adults.Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid-Resistant Nephrotic SyndromeRenal function and proteinuria after successful immunosuppressive therapies in patients with FSGS.The expression of cytoskeletal proteins in kidney specimens of children with primary focal segmental glomerulosclerosis.Changing the Paradigm for the Treatment and Development of New Therapies for FSGS.Ankle brachial index in children with steroid-resistant nephrotic syndromeThe Genetics of Nephrotic Syndrome.Childhood nephrotic syndrome--current and future therapies.Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO.Treatment outcome of late steroid-resistant nephrotic syndrome: a study by the Midwest Pediatric Nephrology Consortium.Primary focal and segmental glomerulosclerosis and soluble factor urokinase-type plasminogen activator receptorRituximab treatment for relapsing minimal change disease and focal segmental glomerulosclerosis: a systematic review.Interventions for idiopathic steroid-resistant nephrotic syndrome in children.Immunosuppressive therapy in children with steroid-resistant, frequently-relapsing, and steroid-dependent idiopathic nephrotic syndrome: a single center experienceUrinary Vitamin D-Binding Protein as a Biomarker of Steroid-Resistant Nephrotic Syndrome.Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children.A Novel Biomarker Panel to Identify Steroid Resistance in Childhood Idiopathic Nephrotic Syndrome.Efficacy and safety of immunosuppressive medications for steroid-resistant nephrotic syndrome in children: a systematic review and network meta-analysisSecond-line options for refractory steroid-sensitive and -resistant nephrotic syndrome.Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.Efficacy and Safety of Sparsentan Compared With Irbesartan in Patients With Primary Focal Segmental Glomerulosclerosis: Randomized, Controlled Trial Design (DUET).An Outcomes-Based Definition of Proteinuria Remission in Focal Segmental Glomerulosclerosis.Difficult Renal Pathological Classification in a Case of Pediatric Nephrotic Syndrome.Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.Long-Term Outcome of Steroid-Resistant Nephrotic Syndrome in Children.Efficacy of rituximab therapy against intractable steroid-resistant nephrotic syndrome.Proliferative changes of renal arteriolar walls induced by administration of angiotensin II receptor blocker are frequent in juvenile rats.
P2860
Q26827717-9D1FD563-F6B4-40F9-9B1E-099E94C3F288Q28534316-F9E9FE7C-BD70-4335-8A42-C60F1A53DB0AQ29994584-FDFB1AAE-F38A-4AFA-8487-03B39BF1D234Q33904402-FE4F1E9A-5773-4A53-B5C4-0A47DF27B65CQ34405321-B801CC72-B200-45BD-BAFE-6E483AEDC379Q34997491-AA1E2580-F7DD-4E25-BF48-EEF26184F69CQ35614311-374D7B43-0939-4705-8E2B-CA24AD4D4F39Q35704498-1E673860-1460-4877-8234-CE40C8F00C85Q35837532-F2D1165C-DC1E-432D-98B4-439531501712Q36543103-62720AFE-9C98-4674-BEF9-5EA748380023Q36583388-80A289ED-28BD-4D2F-A71C-1503895F609AQ36612823-9B056B4E-4416-43E4-B49C-5DB26E1F051CQ36717656-B2079056-5408-442E-B14F-65A0BCEFCB5CQ36741100-A3CF9D64-0936-4A43-AF29-6DFB7F4596E5Q37032671-5E39FFE4-34F9-442D-B6F0-3AB6FF5D74B2Q38017937-E826F7D9-7843-49DF-98B9-E33F9D792297Q38050959-321D9C8C-CBB5-4803-AC44-88F46ABC0849Q38103188-31F96EE9-7A34-4229-9F50-DE45CADB4AE2Q38164339-4B0EE0B3-F2F3-4346-ADDF-CC9D9B6DC3B8Q38206050-FBE15437-4DA3-4EE0-8594-0E95AABDC53EQ38801673-78A3C1C7-9322-4576-B536-212897496D5FQ39881156-97BC6105-42FB-4457-9555-B1AE106F44D4Q40080256-AF1B7764-E26D-4086-B10C-ED45CE453D71Q40579169-83D0FEB1-C0D6-4214-A99D-E74A237B6D9AQ42203151-18116CA2-3B7A-4DAB-B28D-E7EDB8E15F48Q42700702-81E6C706-581D-4D4F-98C4-BBA4D4FEDA30Q42723614-0E23AE31-9A77-4AF2-B7A9-245F99EFC718Q43805398-925BDD41-CC46-4B0F-BA35-61D59EFDDA87Q46399341-5E1AA5CF-9CC5-407A-93AD-CB0E9F809355Q47372786-B3778425-151A-4B60-A667-0B080C9554C9Q49767678-B2243FB2-9036-400B-B515-F7DCEEE1E49FQ50625785-A2D59996-7938-4D27-8A9D-29CEB94CB79BQ52838570-1D365825-47C2-40B6-90B8-10A4B05831C4Q53762906-83521BB4-B5CD-4783-BF4D-12FD7EFB3BF5Q54614581-C7423509-C783-48FD-A8C3-B45AEF3DBD99
P2860
Differential risk of remission and ESRD in childhood FSGS.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Differential risk of remission and ESRD in childhood FSGS.
@en
Differential risk of remission and ESRD in childhood FSGS.
@nl
type
label
Differential risk of remission and ESRD in childhood FSGS.
@en
Differential risk of remission and ESRD in childhood FSGS.
@nl
prefLabel
Differential risk of remission and ESRD in childhood FSGS.
@en
Differential risk of remission and ESRD in childhood FSGS.
@nl
P2093
P1433
P1476
Differential risk of remission and ESRD in childhood FSGS.
@en
P2093
Caroline Jennette
David B Thomas
Hyunsook Chin
Keisha Gibson
Maria E Ferris
Susan Massengill
Trevor P Presler
P2888
P304
P356
10.1007/S00467-005-2097-0
P577
2006-01-05T00:00:00Z